Key opportunities in the Human Metapneumovirus Diagnostics Market include the growing use of multiplex testing panels for ...

Northwestern scientists have created the fastest-ever hepatitis C diagnostic, delivering accurate results in only 15 minutes. The test uses the DASH rapid PCR system, originally developed for COVID, ...

Consumers Now Have More Choices to Purchase the Visby Device Featuring 30-Minute, Lab-Quality Results Today, Visby Medical announced two new relationships that will expand national access to the Visby ...

A newly cleared point-of-care test will enable rapid identification of whooping cough, according to a press release from manufacturer Roche. The molecular test uses the cobas liat system and earned an ...

Veterans Day 2025 is observed today, Nov. 11 to celebrate and honor those who served or continue to serve our country, with restaurants offering free meals, deals, discounts, and freebies to veterans ...

Patients in rural communities often lack timely access to innovative infectious disease testing because diagnostic laboratories are located far away. Long transport times and logistical barriers delay ...

Woven City simulates urban environment for tech testing 300 residents to live on site in first phase, expanding to 2,000 Global automotive industry has been shifting rapidly towards electrification, ...

A new biotechnology company in McKinney has ambitions to become the world’s first fully integrated platform for polymerase chain reaction (PCR) testing — the same technology behind a common COVID-19 ...

What are “near me” searches and why do they matter? “Near me” searches are high-intent, proximity-driven queries that include language like “near me” or “nearby” to land local search results. For ...

An expert panel convened by the nation’s top post-acute care medical organization has recommended against the routine use of urine PCR tests to diagnose urinary tract infections. Such tests have ...

Phase 1 trial of SHR-A2102, a nectin-4–directed antibody drug conjugate (ADC), in advanced solid tumors. Prediction of survival after de-escalated neoadjuvant therapy in HER2+ early breast cancer: A ...